EC BORDEN, JF HOLLAND, TL DAO, JU … - Annals of Internal Medicine, 1982 - Am Coll Physicians A multi-institutional trials program was initiated to define the effects of
interferons in disseminated human breast carcinoma. Interferon alpha, prepared
from buffy coats, was administered intramuscularly at 3 x10 6 U daily for ... Cited by 95 - Related articles - All 2 versions
SA SHERWIN, D MAYER, JJ OCHS, PG … - Annals of Internal Medicine, 1983 - Am Coll Physicians Nineteen patients with advanced refractory metastatic breast cancer no longer
responsive to chemotherapy were treated in the first phase II efficacy trial of
recombinant leukocyte A interferon (IFL-rA), a highly purified single ... Cited by 41 - Related articles - All 2 versions
… , R ALEXANIAN, HY YAP, AU BUZDAR, F … - Annals of Internal Medicine, 1980 - Am Coll Physicians Thirty-eight patients with advanced breast cancer, multiple myeloma, and
malignant lymphoma were treated with partially purified (about 0.1%) leukocyte
interferon. Patients were treated with a remission-induction schedule of 3 ... Cited by 316 - Related articles - All 2 versions
- ►bloodjournal.org [PDF] AC Louie, JG Gallagher, K Sikora, R Levy, … - Blood, 1981 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 83 - Related articles - All 3 versions
JR Quesada, M Hawkins, S Horning, R … - The American journal of medicine, 1984 - Elsevier Fifty-two patients with advanced cancer received sequentially escalating doses
of 3 to 50 million units of recombinant DNA-produced alpha interferon by daily
intramuscular injection. There were 23 patients with metastatic breast ... Cited by 70 - Related articles - All 4 versions
SA Sherwin, JA Knost, S Fein, PG Abrams, … - Jama, 1982 - Am Med Assoc Eighty-one patients with a variety of refractory disseminated malignant
neoplasms have been treated in the first multiple fixed-dose phase I trial of
recombinant leukocyte A interferon (IFL-rA). Each patient received IFL-rA ... Cited by 116 - Related articles - All 3 versions
TC Merigan, K Sikora, JH Breeden, R Levy, … - The New England journal of medicine, 1978 - ncbi.nlm.nih.gov 1: N Engl J Med. 1978 Dec 28;299(26):1449-53. Preliminary observations on the
effect of human leukocyte interferon in non-Hodgkin's lymphoma. ... Cited by 188 - Related articles - All 2 versions
S Retsas, TJ Priestman, KA Newton, G … - CA A Cancer Journal for Clinicians - interscience.wiley.com Seventeen patients with metastatic disease from malignant melanoma received
treatment with injections of Human lymphoblastoid interferon. Fifteen of these
had the drug by intramuscular injections. One started treatment by the ... Cited by 52 - Related articles - All 3 versions
- ►ascopubs.org [PDF] HB Muss, RA Kempf, S Martino, SA Rudnick, J … - Journal of Clinical Oncology, 1984 - jco.ascopubs.org METASTATIC breast cancers are rarely curable. Although beneficial palliative re-
sponses can be obtained with hormonal therapy, chemotherapy, or both, these
responses rarely last longer than one to two years." Patients with steroid ... Cited by 15 - Related articles - All 5 versions
AE Maluish, JR Ortaldo, JC Conlon, SA … - The Journal of Immunology, 1983 - Am Assoc Immnol ANNETTE E. MALUISH,* JOHN R. ORTALDO, JOHN C. CONLON, STEPHEN A. SHERWIN,
RICHARD LEAVIlT, DOUGLAS M. STRONG, PETER WEIRNIK, ROBERT ... From the
Biological Therapeutics Branch, Biological Response Modifiers Program, ... Cited by 89 - Related articles - All 2 versions
